Your browser doesn't support javascript.
loading
p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer.
Zarczynska, Izabela; Gorska-Arcisz, Monika; Cortez, Alexander Jorge; Kujawa, Katarzyna Aleksandra; Wilk, Agata Malgorzata; Skladanowski, Andrzej Cezary; Stanczak, Aleksandra; Skupinska, Monika; Wieczorek, Maciej; Lisowska, Katarzyna Marta; Sadej, Rafal; Kitowska, Kamila.
Afiliação
  • Zarczynska I; Department of Molecular Enzymology and Oncology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland.
  • Gorska-Arcisz M; Department of Molecular Enzymology and Oncology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland.
  • Cortez AJ; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland.
  • Kujawa KA; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland.
  • Wilk AM; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland.
  • Skladanowski AC; Department of Systems Biology and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.
  • Stanczak A; Department of Molecular Enzymology and Oncology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland.
  • Skupinska M; Clinical Development Department, Celon Pharma S.A., Marymoncka 15, 05-152 Kazun Nowy, Poland.
  • Wieczorek M; Preclinical Development Departament, Celon Pharma S.A., Marymoncka 15, 05-152 Kazun Nowy, Poland.
  • Lisowska KM; Clinical Development Department, Celon Pharma S.A., Marymoncka 15, 05-152 Kazun Nowy, Poland.
  • Sadej R; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland.
  • Kitowska K; Department of Molecular Enzymology and Oncology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland.
Cells ; 10(12)2021 11 30.
Article em En | MEDLINE | ID: mdl-34943871
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Proteínas Quinases p38 Ativadas por Mitógeno / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Proteínas Quinases p38 Ativadas por Mitógeno / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça